# iShares Nasdaq Biotechnology Index Fund (IBB)

Source: https://www.quantisnow.com/company/IBB
Generated: 2026-11-09T03:50:46.544Z

- Type: ETF (exchange-traded fund), not a company
- Ticker: IBB
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## About

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.
 The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

## Latest IBB news and filings

- 2024-12-19 12:30 UTC [Altimmune Added to Nasdaq Biotechnology Index](https://www.quantisnow.com/insight/altimmune-added-to-nasdaq-biotechnology-index-5819733)
- 2024-07-01 17:38 UTC [Market Insight] [Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows](https://www.quantisnow.com/insight/top-performing-industry-etfs-in-june-software-leads-returns-chipmakers-5586265)
- 2024-06-21 17:34 UTC [Market Insight] [Stocks Stalls As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?](https://www.quantisnow.com/insight/stocks-stalls-as-chip-sector-struggles-to-rebound-dollar-eyes-5570674)
- 2024-04-30 20:38 UTC [Market Insight] [April Showers On Wall Street:  Miners, Utilities Emerge As Bright Spots In Gloomy Market](https://www.quantisnow.com/insight/april-showers-on-wall-street-miners-utilities-emerge-as-bright-5445819)
- 2024-01-29 14:02 UTC [Market Insight] [AI, Biotech, Energy Sectors Expect M&A Revival For 2024](https://www.quantisnow.com/insight/ai-biotech-energy-sectors-expect-ma-revival-for-2024-5212899)
- 2024-01-05 17:42 UTC [Market Chatter] [Live On CNBC, Jason Snipe's Contrarian Idea: Biotech; Names IShares Biotechnology ETF](https://www.quantisnow.com/insight/live-on-cnbc-jason-snipes-contrarian-idea-biotech-names-ishares-5172724)
- 2024-01-03 18:23 UTC [Market Insight] [US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?](https://www.quantisnow.com/insight/us-stocks-eye-3-day-slump-tech-crypto-sell-off-deepens-oil-5164103)
- 2024-01-02 18:29 UTC [Market Insight] [Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?](https://www.quantisnow.com/insight/tech-drags-on-wall-street-as-2024-kicks-off-dollar-5160972)
- 2023-12-29 13:34 UTC [Market Insight] [Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback](https://www.quantisnow.com/insight/top-biotech-picks-for-2024-piper-sandler-foresees-potential-sector-5158396)
- 2023-12-26 17:47 UTC [Market Insight] [Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?](https://www.quantisnow.com/insight/wall-street-sees-post-holiday-gains-oil-rallies-intel-leads-whats-5154736)
- 2023-12-22 18:04 UTC [Market Insight] [S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?](https://www.quantisnow.com/insight/sp-500-nasdaq-100-aim-for-8th-week-of-gains-5152973)
- 2023-12-21 19:11 UTC [Market Insight] [US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday?](https://www.quantisnow.com/insight/us-stocks-bounce-chipmakers-cruise-lines-lead-dollar-falls-whats-5150937)
- 2023-12-20 18:47 UTC [Market Insight] [Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday?](https://www.quantisnow.com/insight/wall-street-edges-higher-small-caps-eye-best-month-in-5148802)
- 2023-11-07 21:12 UTC [Market Insight] [Activist Investor Elliott Pushes for Strategy Revamp at BioMarin Amid CEO Change](https://www.quantisnow.com/insight/activist-investor-elliott-pushes-for-strategy-revamp-at-biomarin-amid-5066204)
- 2023-08-31 16:49 UTC [Market Insight] [Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed](https://www.quantisnow.com/insight/industry-etfs-in-the-spotlight-winners-and-losers-of-the-4947599)
- 2023-08-12 19:31 UTC [Market Insight] [Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP](https://www.quantisnow.com/insight/weight-loss-drug-wegovy-adds-mass-to-novo-nordisks-stock-pushing-4887157)
- 2023-08-10 15:58 UTC [Market Insight] [Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss](https://www.quantisnow.com/insight/disinflation-talk-grows-rate-hike-bets-plummet-top-5-etfs-4876793)
- 2023-07-31 14:59 UTC [Market Insight] [Rising Stars, Falling Trends: July's Industry ETF Winners and Losers](https://www.quantisnow.com/insight/rising-stars-falling-trends-julys-industry-etf-winners-and-losers-4817708)
- 2023-04-13 18:54 UTC [Market Insight] [Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention](https://www.quantisnow.com/insight/mifepristone-abortion-pill-access-in-limbo-justice-department-may-ask-4332955)
- 2023-04-13 11:38 UTC [Market Insight] [Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules](https://www.quantisnow.com/insight/womens-reproductive-rights-us-court-preserves-access-to-abortion-pill-4330095)
- 2023-04-12 13:46 UTC [Market Insight] [New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications](https://www.quantisnow.com/insight/new-york-and-california-prepare-for-potential-mifepristone-ban-in-4325971)
- 2023-04-11 18:28 UTC [Market Insight] [Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead](https://www.quantisnow.com/insight/attorney-generals-of-over-20-states-sound-alarm-over-suspension-4322274)
- 2023-04-06 17:45 UTC [Market Insight] [FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits](https://www.quantisnow.com/insight/fda-withdraws-lone-premature-birth-drug-makena-over-lack-of-4309080)
- 2023-04-06 12:49 UTC [Market Insight] [AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades'](https://www.quantisnow.com/insight/abbvie-thermo-fisher-scientific-and-a-must-watch-biotech-etf-cnbcs-4307107)
- 2023-03-16 12:56 UTC [Market Insight] [US Judge Weighs Nationwide Ban On Abortion Pills](https://www.quantisnow.com/insight/us-judge-weighs-nationwide-ban-on-abortion-pills-4210530)
- 2023-03-13 12:05 UTC [Market Insight] [Silicon Valley Bank Meltdown Hits Healthcare Sector As Well](https://www.quantisnow.com/insight/silicon-valley-bank-meltdown-hits-healthcare-sector-as-well-4190725)
- 2023-03-10 18:10 UTC [Market Insight] [Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs](https://www.quantisnow.com/insight/hefty-listing-price-of-new-drugs-for-cancer-rare-diseases-4186330)
- 2023-03-10 16:46 UTC [Market Insight] [FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities](https://www.quantisnow.com/insight/fda-seeks-10-increase-in-bidens-fy-2024-budget-proposes-4185898)
- 2023-03-08 10:21 UTC [Market Insight] [Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births](https://www.quantisnow.com/insight/covis-pharma-to-withdraw-only-fda-approved-treatment-to-prevent-preterm-4170771)
- 2023-03-08 00:34 UTC [Market Insight] [Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason](https://www.quantisnow.com/insight/health-care-etfs-have-lost-in-the-last-month---4170179)
- 2023-03-01 18:24 UTC [Market Insight] [FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'](https://www.quantisnow.com/insight/fda-takes-action-to-restrict-unlawful-import-of-animal-tranquilizer-4144364)
- 2023-02-20 18:14 UTC [Market Insight] [Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine](https://www.quantisnow.com/insight/man-in-germany-cured-of-hiv-after-undergoing-stem-cell-4087364)
- 2023-01-31 19:33 UTC [Market Insight] [February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More](https://www.quantisnow.com/insight/february-pdufa-catalysts-biotech-investors-must-know-sanofis-bleeding-disorder-3980778)
- 2023-01-06 20:17 UTC [Market Chatter] [Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug](https://www.quantisnow.com/insight/longeveron-shares-surge-following-fda-decision-on-biogen-alzheimers-drug-3884139)
- 2023-01-06 19:47 UTC [Market Chatter] [SAVA, LLY, IBB: Why The Alzheimer's Related Stocks Are Volatile On Friday](https://www.quantisnow.com/insight/sava-lly-ibb-why-the-alzheimers-related-stocks-are-volatile-3884007)
- 2022-12-27 14:11 UTC [Market Insight] [Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors](https://www.quantisnow.com/insight/biogens-2nd-alzheimers-antibody-beigenes-cancer-drug-label-expansion-adcom-3845085)
- 2022-12-16 12:00 UTC [Tarsus Added to NASDAQ Biotechnology Index](https://www.quantisnow.com/insight/tarsus-added-to-nasdaq-biotechnology-index-3814968)
- 2022-12-05 13:23 UTC [Market Insight] [Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'](https://www.quantisnow.com/insight/meta-platforms-this-biotech-etf-and-these-china-plays-are-3765470)
- 2022-12-02 11:01 UTC [Market Insight] [Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors](https://www.quantisnow.com/insight/mirati-plays-catch-up-with-amgen-gileads-2nd-try-with-aids-3759330)
- 2022-11-01 20:01 UTC [Market Insight] [Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know](https://www.quantisnow.com/insight/provention-bios-second-try-apelliss-eye-disorder-drug-review-3-3611270)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IBB
- Earnings history: https://www.quantisnow.com/earnings/IBB
- Dividend history: https://www.quantisnow.com/dividends/IBB
- Insider transactions: https://www.quantisnow.com/insiders/IBB
- Options chain: https://www.quantisnow.com/options/IBB
- SEC 8-K filings only: https://www.quantisnow.com/company/IBB/8-k
- RSS and alerts for IBB: https://www.quantisnow.com/docs/rss-feeds.md